Acadian Asset Management
CAPR icon

Acadian Asset Management’s Capricor Therapeutics CAPR Stock Holding History

Acadian Asset Management’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,100
Closed -$579K – 2037
2025
Q4 		$579K Buy
+20,100
New +$262K ﹤0.01% 1263
2020
Q2 		– Sell
-10,427
Closed -$13K – 2228
2020
Q1 		$13K Hold
10,427
– – ﹤0.01% 1690
2019
Q4 		$13K Buy
+10,427
New +$21.5K ﹤0.01% 1745
2018
Q3 		– Sell
-1,195
Closed -$16K – 1669
2018
Q2 		$16K Sell
1,195
-4,880
-80% -$66.4K ﹤0.01% 1544
2018
Q1 		$82K Buy
6,075
+1,326
+28% +$23K ﹤0.01% 1263
2017
Q4 		$75K Buy
+4,749
New +$103K ﹤0.01% 1156

Other funds holding CAPR

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JHC
Jones Hill Capital New York $470M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Acadian Asset Management's CAPR Position: Q1 2026 in Review

Acadian Asset Management sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 20,100 shares — an estimated $579K sold.

Acadian Asset Management first reported a position in CAPR in Q4 2017 and held it in 6 quarters. The position peaked at $579K in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Acadian Asset Management reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Acadian Asset Management sold 20,100 Capricor Therapeutics shares in Q1 2026, an estimated $579K.
  • Acadian Asset Management first reported a position in Capricor Therapeutics in Q4 2017 and held it in 6 quarters.
  • Acadian Asset Management's Capricor Therapeutics position peaked at $579K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.